Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HCFC2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | CDK5R1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | C12orf43 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | C1orf210 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | NSMAF | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | GPRIN1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | TSPAN16 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | LRRC71 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | SLC2A4 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | EGF | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |